(19)
(11) EP 4 680 617 A1

(12)

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24771593.1

(22) Date of filing: 12.03.2024
(51) International Patent Classification (IPC): 
C07K 1/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/12; C12N 9/22; C12N 15/113; A61K 48/005; A61K 48/0075; A61K 48/0041; C12N 15/88; A61K 9/0043; A61K 9/5068; C12N 9/78; C07K 2319/80; C07K 14/4702; C12N 2310/20; C12N 2320/32; C12Y 301/00; A61K 38/00
(86) International application number:
PCT/US2024/019566
(87) International publication number:
WO 2024/192023 (19.09.2024 Gazette 2024/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 13.03.2023 US 202363451898 P

(71) Applicant: Turn Biotechnologies, Inc.
Mountain View, CA 94043 (US)

(72) Inventors:
  • NABHAN, Joseph
    Cambridge, Massachusetts 02139 (US)
  • ZHAO, Wen-Ning
    Cambridge, Massachusetts 02139 (US)
  • WANG, Qiyu
    Cambridge, Massachusetts 02139 (US)

(74) Representative: Fish & Richardson P.C. 
Highlight Business Towers Mies-van-der-Rohe-Straße 8
80807 München
80807 München (DE)

   


(54) ARRDC1-MEDIATED MICROVESICLE-BASED DELIVERY OF RNA-GUIDED PROTEINS